A China-based medical device company that develops, manufactures & markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence technology & Fluorescent in situ Hybridization technology, to detect & monitor various diseases & disorders.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Even the SEC thinks Comedy the Pink is a joke, but unfortunately for me they didn't halt it until after CHina Medical Technologies, Inc took me for a 100 point blood bath. If the SEC decides to delist it instead of letting it trade again, then I"ll eat those points. A hedge fund was buying it up and raising the price, presumably so a company insider could take it private as has recently happened to a few other reverse merger China plays, such as Harbinger at $20 (HRBN) and now possibly Fushi Copperweld, Inc. (FSIN).
I felt this was unlikely because China Medical had a huge bond outlay. Because it had gone "dark", they were being recalled with interest.
We will see if it reopens July 14th. It's already on the Pink sheets, what's the SEC going to do about confusing management, confusing books, confusing price action, etc.
http://www.sec.gov/litigation/suspensions/2012/34-67311-o.pdf
The SEC can always close the barn doors after the horses are stolen. In this era of crony capitalism and captured regulators that would be a major accomplishment...